Thermo Fisher Collaborates with NanoPin to Facilitate Infectious Diseases Diagnosis

 Thermo Fisher Collaborates with NanoPin to Facilitate Infectious Diseases Diagnosis

Thermo Fisher Collaborates with NanoPin to Facilitate Infectious Diseases Diagnosis

Shots:

  • The companies collaborated to develop highly sensitive liquid chromatography-mass spectrometry (LC-MS)-based workflows for advancing blood-based infectious disease detection technology
  •  The collaboration leverages NanoPin’s diagnostic platform and Thermo Fisher’s LC-MS technology to develop clinical assays for infectious disease for determining infection stage and monitor patient response to treatment
  • The collaboration may lead to a change in detection & treatment of infectious disease by targeting unmet medical needs of HCPs managing patient care across the globe

Click here ­to­ read full press release/ article | Ref: Thermofisher | Image: Market Watch

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post